Crapo in Omni est
This article was originally published in Scrip
Executive Summary
Omni Bio Pharmaceutical has announced that Dr James Crapo is to become its chief executive officer, effective 1 March. Dr Charles Dinarello, who has served as Omni Bio's acting CEO since its inception in March 2009, will become chief scientific officer and chief medical director. Dr Crapo has served on Omni Bio's scientific advisory board since March 2009. He is currently a professor at National Jewish Medical and Research Center and served as its executive vice-president of academic affairs and chairman of medicine from 1996-2004.